1. Home
  2. NNNN vs VRXA Comparison

NNNN vs VRXA Comparison

Compare NNNN & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$9.25

Market Cap

417.8M

Sector

Health Care

ML Signal

HOLD

Logo Veraxa Biotech AG Ordinary Shares

VRXA

Veraxa Biotech AG Ordinary Shares

N/A

Current Price

$1.78

Market Cap

390.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NNNN
VRXA
Founded
2021
N/A
Country
Germany
Switzerland
Employees
27
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
417.8M
390.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NNNN
VRXA
Price
$9.25
$1.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.6K
951.5K
Earning Date
04-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$446.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.30
$1.70
52 Week High
$54.90
$4.50

Technical Indicators

Market Signals
Indicator
NNNN
VRXA
Relative Strength Index (RSI) 37.56 29.98
Support Level $8.30 $1.74
Resistance Level $29.98 $2.29
Average True Range (ATR) 1.31 0.20
MACD 0.58 0.04
Stochastic Oscillator 33.89 13.46

Price Performance

Historical Comparison
NNNN
VRXA

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

About VRXA Veraxa Biotech AG Ordinary Shares

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: